Viewing Study NCT00659958


Ignite Creation Date: 2025-12-25 @ 12:18 AM
Ignite Modification Date: 2026-04-16 @ 4:57 PM
Study NCT ID: NCT00659958
Status: COMPLETED
Last Update Posted: 2013-05-13
First Post: 2008-04-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs
Sponsor: Eisai Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: E2090-E044-407
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View